{"data":{"id":18431,"title":"Kaizen: Risk Assessment","rsi_url":"https:\/\/robertsspaceindustries.com\/comm-link\/spectrum-dispatch\/18431-Kaizen-Risk-Assessment","api_url":"https:\/\/api.star-citizen.wiki\/api\/comm-links\/18431","api_public_url":"https:\/\/api.star-citizen.wiki\/comm-links\/18431","channel":"Undefined","category":"Undefined","series":"News Update","images":[{"id":389,"name":"KaizenLogoFL3.jpg","rsi_url":"https:\/\/robertsspaceindustries.com\/media\/06567oxyhksh9r\/source\/KaizenLogoFL3.jpg","alt":"","size":946019,"mime_type":"image\/jpeg","last_modified":"2013-07-19T05:23:18+00:00","api_url":"https:\/\/api.star-citizen.wiki\/api\/comm-link-images\/389","similar_url":"https:\/\/api.star-citizen.wiki\/api\/comm-link-images\/389\/similar"},{"id":26463,"name":"source.jpg","rsi_url":"https:\/\/media.robertsspaceindustries.com\/weozjmuuh3hwh\/source.jpg","alt":"","size":843046,"mime_type":"image\/jpeg","last_modified":"2019-09-19T15:49:32+00:00","api_url":"https:\/\/api.star-citizen.wiki\/api\/comm-link-images\/26463","similar_url":"https:\/\/api.star-citizen.wiki\/api\/comm-link-images\/26463\/similar"},{"id":27892,"name":"source.jpg","rsi_url":"https:\/\/media.robertsspaceindustries.com\/w3o9r4zgppm77\/source.jpg","alt":"","size":900916,"mime_type":"image\/jpeg","last_modified":"2021-09-06T14:48:40+00:00","api_url":"https:\/\/api.star-citizen.wiki\/api\/comm-link-images\/27892","similar_url":"https:\/\/api.star-citizen.wiki\/api\/comm-link-images\/27892\/similar"}],"images_count":8,"translations":{"en_EN":"START TRANSMISSION:\nHi, thanks for joining another installment of Kaizen. I\u2019m Aaron Schere, here to help you set a course for financial solvency. Sasha Bart is back with us today to talk about potential profits and pitfalls in the booming medical and insurance industry. But first, it\u2019s time for a Market Breakdown.\n\nPast performance is not indicative of future results. Neither Schere, Kaizen, nor Farnes Media Partners guarantees any specific outcome or profit. Before acting on information in this program, you should strongly consider seeking advice from your own financial or investment adviser.\nMarkets are already on the move thanks to the IAE rumor mill. With this year\u2019s big event almost here, spectrum has been flooded with speculation and anonymous reports credited to \u201cindustry insiders.\u201d A quick reminder that the duration of the IAE remains an extremely volatile time for aerospace industry stocks. Investors should proceed cautiously as history has proven time and again that information leaked before the expo is often incomplete or simply wrong. That said, the gains and losses are still very real.\n\nRSI and Anvil have seen steady growth ahead of what many expect to be a strong showing from both manufacturers. Meanwhile, MISC\u2019s stock price has fluctuated wildly after a highly coordinated outlaw attack on one of its transports sparked rumors that its presence at the expo might be affected. MISC has publicly denied these claims and insisted that everything it needs for the main expo in Kiel is already in-system. Some noted the company specified Kiel but made no mention of the satellite expo on microTech, leaving some to wonder if the omission was a mistake or intentional. Since the initial rumors, MISC\u2019s stock price has stabilized after deal-seeking investors pounced on the falling price.\n\nNext, insurance giant Olympus Principal continues to expand its footprint across the empire. The company recently completed a series of buyouts of smaller insurance companies, most with a presence only in a single system. These takeovers will not only expand the insurance giant\u2019s client base, but also land it new locations in prime landing zones and rest stops across the empire. Investors were energized by the announcement and pushed Olympus Principal\u2019s stock to a new all-time high.\n\nHere with us today to discuss the current state of the medical and insurance industry is Sasha Bart, who\u2019s a senior economic correspondent for the New United and a frequent guest on this show.\n\nSasha Bart: Always a pleasure.\nYour latest series for the New United has focused on the medical and insurance sectors. The final installment that came out this week is the culmination of months spent delving into an ever-expanding and shifting financial landscape. It\u2019s a wonderful series and I highly encourage everyone to read it regardless of whether you\u2019re looking to invest.\n\nSasha Bart: Appreciate the kind words.\nYour most recent article profiled a handful of businesses and identified several potential booms and busts in both sectors. Before we drill down into the details, let\u2019s talk about the sector as a whole. Obviously, regen tech has had a profound effect on it.\n\nSasha Bart: Seismic. Both on a macroeconomic scale and a more personal one. One of my favorite parts of this assignment was tracking down several actuaries who were working for insurance companies when news of regen tech broke. As their primary focus is around risk management, needless to say, they have some wild stories about that time.\nI can only imagine.\n\nSasha Bart: Burnout became a serious issue, and many of them walked away from lucrative jobs. Insurance companies ran their actuaries ragged trying to figure out how to factor \u201cregen\u201d into their algorithms.\nDidn\u2019t one person you spoke to have to physically restrain a co-worker from jumping out the window?\n\nSasha Bart: In that one case, yes, but most reactions weren\u2019t that extreme. Several were even celebratory. And all of them had a specific memory about seeing the new projections or sharing them with co-workers for the first time.\nCelebratory? Seems a little presumptuous after an initial report.\n\nSasha Bart: Well, some saw the potential immediately. And that was before the UEE allocated trillions to help make regen tech widely available. That influx of credits combined with the public release of the Ibrahim Sphere blueprints so anyone could manufacture the tech sent the sector into QT.\nImperator Addison gets full credit for championing these measures, but several people you spoke with argued that it\u2019s been too much, too fast.\n\nSasha Bart: One person compared it to turning an Idris. It can be done fast and reckless or slow and steady. She worked for a small insurance firm with only a few branches in Ellis that struggled to process all the claims pouring in. Their system is mostly automated but some cases still need Human vetting. It was her and like three other people drowning in a backlog of claims.\nWeren\u2019t some of those government credits allocated just for businesses that needed to hire more employees or upgrade critical infrastructure?\n\nSasha Bart: Yes, and those credits definitely helped. Several businesses on my list told me that they wouldn\u2019t have been able to adjust to the new landscape without it. However, I discovered that in a lot of cases, particularly for small and medium sized insurance companies, buyout offers from giants like Olympus Principal were way more lucrative. Much less of a hassle too because, you know, they could just walk away with the credits instead of still running the business.\nConsolidation isn\u2019t only happening in the insurance sector it seems. You\u2019ve reported that there are fewer cybernetic manufacturers today than before regen tech came online.\n\nSasha Bart: Yeah, early numbers showed a sizable jump in the demand for cybernetics due to people\u2019s willingness to engage in riskier behavior. So larger manufacturers began bidding against each other to acquire smaller firms. Partially to limit competition, but mostly to gain access to their supply chain and manufacturing centers. They saw a surge in demand coming and were desperate to get ahead of it.\nAnd despite these efforts there are still shortages of implants in some corners of the empire. Believe one person you spoke to described the task of keeping up with the demand as trying to catch a crashing wave with your arms.\n\nSasha Bart: Several issues arose from this wave of consolidation, including one major manufacturer using in-house software that didn\u2019t work with the machines in several of the facilities they acquired. Those production lines were shut down for weeks until the software was patched. It\u2019s also proven hard to ramp up the supply chain to meet the increased demand. Cybernetics aren\u2019t simply raw materials. Depending on the part, they require refined materials and components, many of which other medical devices also use. So a lot of these cybernetic manufacturers can\u2019t increase their production runs unless they\u2019re willing to pay exorbitant prices for the right materials.\nThat seems to encapsulate this sector for many investors: potential for profit and so much risk. I\u2019d like to shift now to your latest article highlighting several medical and insurance businesses that you believe will boom and several that will bust, but before we do that, we need to take a quick commercial break. Stay here for further insights from the New United\u2019s Sasha Bart and more when Kaizen returns.","de_DE":"\u00dcBERTRAGUNG STARTEN:\nHallo, danke, dass Sie bei einer weiteren Ausgabe von Kaizen dabei sind. Ich bin Aaron Schere und helfe Ihnen dabei, einen Kurs f\u00fcr die finanzielle Solvenz zu setzen. Sasha Bart ist heute wieder bei uns und spricht \u00fcber m\u00f6gliche Gewinne und Fallstricke in der boomenden Medizin- und Versicherungsbranche. Aber zun\u00e4chst ist es Zeit f\u00fcr einen Markt\u00fcberblick.\n\nDie vergangene Performance ist kein Indikator f\u00fcr zuk\u00fcnftige Ergebnisse. Weder Schere, Kaizen, noch Farnes Media Partners garantieren ein bestimmtes Ergebnis oder einen Gewinn. Bevor Sie aufgrund der Informationen in diesem Programm handeln, sollten Sie unbedingt Ihren eigenen Finanz- oder Anlageberater konsultieren.\nDie M\u00e4rkte sind dank der Ger\u00fcchtek\u00fcche der IAE bereits in Bewegung. Da das diesj\u00e4hrige Gro\u00dfereignis kurz bevorsteht, wurde das Spektrum mit Spekulationen und anonymen Berichten \u00fcberschwemmt, die \"Brancheninsidern\" zugeschrieben werden. Wir m\u00f6chten Sie kurz daran erinnern, dass die Dauer der IAE f\u00fcr Aktien der Luft- und Raumfahrtindustrie eine extrem volatile Zeit ist. Anleger sollten vorsichtig vorgehen, denn die Geschichte hat immer wieder bewiesen, dass Informationen, die vor der Messe durchsickern, oft unvollst\u00e4ndig oder schlichtweg falsch sind. Abgesehen davon sind die Gewinne und Verluste immer noch sehr real.\n\nRSI und Anvil sind im Vorfeld der von vielen erwarteten starken Pr\u00e4sentation beider Hersteller stetig gestiegen. In der Zwischenzeit hat der Aktienkurs von MISC stark geschwankt, nachdem ein hochgradig koordinierter Angriff von Gesetzlosen auf einen seiner Transporter Ger\u00fcchte ausgel\u00f6st hatte, dass die Pr\u00e4senz des Unternehmens auf der Expo betroffen sein k\u00f6nnte. MISC hat diese Behauptungen \u00f6ffentlich dementiert und darauf bestanden, dass alles, was es f\u00fcr die Hauptexpo in Kiel braucht, bereits im System ist. Einige bemerkten, dass das Unternehmen zwar Kiel erw\u00e4hnte, aber die Satellitenausstellung auf microTech nicht erw\u00e4hnte, so dass sich einige fragten, ob die Auslassung ein Fehler oder Absicht war. Seit den ersten Ger\u00fcchten hat sich der Aktienkurs von MISC stabilisiert, nachdem Investoren auf der Suche nach einem Deal auf den fallenden Kurs aufgesprungen sind.\n\nAls n\u00e4chstes expandiert der Versicherungsriese Olympus Principal weiter in seinem ganzen Reich. Das Unternehmen hat vor kurzem eine Reihe von \u00dcbernahmen kleinerer Versicherungsunternehmen abgeschlossen, von denen die meisten nur in einem einzigen System vertreten sind. Diese \u00dcbernahmen erweitern nicht nur den Kundenstamm des Versicherungsriesen, sondern verschaffen ihm auch neue Standorte in erstklassigen Landezonen und Rastst\u00e4tten im ganzen Imperium. Die Investoren waren von der Ank\u00fcndigung begeistert und trieben die Aktie von Olympus Principal auf ein neues Allzeithoch.\n\nSasha Bart, Wirtschaftskorrespondent bei New United und h\u00e4ufiger Gast in dieser Sendung, spricht mit uns \u00fcber die aktuelle Lage in der Medizin- und Versicherungsbranche.\n\nSasha Bart: Es ist mir immer ein Vergn\u00fcgen.\nIn Ihrer letzten Serie f\u00fcr New United haben Sie sich auf die Bereiche Medizin und Versicherungen konzentriert. Die letzte Folge, die diese Woche erschienen ist, ist der H\u00f6hepunkt einer monatelangen Besch\u00e4ftigung mit einer sich st\u00e4ndig erweiternden und ver\u00e4ndernden Finanzlandschaft. Es ist eine wunderbare Serie und ich empfehle jedem, sie zu lesen, unabh\u00e4ngig davon, ob Sie investieren wollen oder nicht.\n\nSasha Bart: Ich danke Ihnen f\u00fcr die freundlichen Worte.\nIn Ihrem j\u00fcngsten Artikel haben Sie eine Handvoll Unternehmen portr\u00e4tiert und mehrere potenzielle Booms und Busts in beiden Sektoren identifiziert. Bevor wir auf die Details eingehen, lassen Sie uns \u00fcber den Sektor als Ganzes sprechen. Offensichtlich hat die Regeneriertechnik einen tiefgreifenden Einfluss auf ihn gehabt.\n\nSasha Bart: Seismisch. Sowohl auf makro\u00f6konomischer Ebene als auch auf pers\u00f6nlicher Ebene. Eine meiner Lieblingsaufgaben bei diesem Auftrag war es, mehrere Versicherungsmathematiker ausfindig zu machen, die f\u00fcr Versicherungsunternehmen arbeiteten, als die Nachricht von der Regenerierungstechnologie bekannt wurde. Da ihr Hauptaugenmerk auf dem Risikomanagement liegt, haben sie nat\u00fcrlich einige wilde Geschichten \u00fcber diese Zeit zu erz\u00e4hlen.\nIch kann es mir nur vorstellen.\n\nSasha Bart: Burnout wurde zu einem ernsten Problem, und viele von ihnen gaben ihre lukrativen Jobs auf. Die Versicherungsgesellschaften haben ihre Versicherungsmathematiker aufgerieben, um herauszufinden, wie sie \"Regeneration\" in ihre Algorithmen einbeziehen k\u00f6nnen.\nMusste nicht einer Ihrer Gespr\u00e4chspartner einen Mitarbeiter k\u00f6rperlich daran hindern, aus dem Fenster zu springen?\n\nSasha Bart: In diesem einen Fall ja, aber die meisten Reaktionen waren nicht so extrem. Einige waren sogar feierlich. Und alle hatten eine bestimmte Erinnerung daran, wie sie die neuen Projektionen zum ersten Mal sahen oder sie mit ihren Kollegen teilten.\nFeiern? Das scheint mir nach einem ersten Bericht ein wenig vermessen zu sein.\n\nSasha Bart: Nun, einige haben das Potenzial sofort erkannt. Und das war, bevor die UEE Billionen bereitstellte, um die Regenerationstechnologie weithin verf\u00fcgbar zu machen. Dieser Zufluss an Krediten in Verbindung mit der Ver\u00f6ffentlichung der Blaupausen f\u00fcr die Ibrahim-Sph\u00e4re, so dass jeder die Technologie herstellen konnte, hat den Sektor ins QT geschickt.\nImperator Addison geb\u00fchrt die volle Anerkennung daf\u00fcr, dass er sich f\u00fcr diese Ma\u00dfnahmen eingesetzt hat, aber mehrere Leute, mit denen Sie gesprochen haben, meinten, es sei zu viel und zu schnell gewesen.\n\nSasha Bart: Eine Person verglich es mit der Verwandlung eines Idris. Man kann es schnell und r\u00fccksichtslos oder langsam und stetig machen. Sie arbeitete f\u00fcr eine kleine Versicherungsgesellschaft mit nur ein paar Filialen in Ellis, die M\u00fche hatte, alle eingehenden Schadensf\u00e4lle zu bearbeiten. Ihr System ist gr\u00f6\u00dftenteils automatisiert, aber einige F\u00e4lle m\u00fcssen immer noch von Menschen bearbeitet werden. Sie und etwa drei weitere Mitarbeiter ertranken in einem R\u00fcckstau von Antr\u00e4gen.\nWurden nicht einige dieser staatlichen Kredite nur f\u00fcr Unternehmen bereitgestellt, die mehr Mitarbeiter einstellen oder kritische Infrastrukturen aufr\u00fcsten mussten?\n\nSasha Bart: Ja, und diese Kredite haben definitiv geholfen. Mehrere Unternehmen auf meiner Liste sagten mir, dass sie ohne diese Kredite nicht in der Lage gewesen w\u00e4ren, sich an die neue Landschaft anzupassen. Ich habe jedoch festgestellt, dass in vielen F\u00e4llen, insbesondere bei kleinen und mittleren Versicherungsunternehmen, die \u00dcbernahmeangebote von Giganten wie Olympus Principal viel lukrativer waren. Und sie waren auch viel unkomplizierter, weil sie sich einfach mit den Krediten davonmachen konnten, anstatt das Gesch\u00e4ft weiterzuf\u00fchren.\nDie Konsolidierung findet nicht nur in der Versicherungsbranche statt, wie es scheint. Sie haben berichtet, dass es heute weniger kybernetische Hersteller gibt als vor der Einf\u00fchrung der Regenerationstechnologie.\n\nSasha Bart: Ja, die ersten Zahlen zeigten einen deutlichen Anstieg der Nachfrage nach Kybernetik, weil die Menschen bereit waren, sich risikoreicher zu verhalten. Also begannen gr\u00f6\u00dfere Hersteller gegeneinander zu bieten, um kleinere Firmen zu \u00fcbernehmen. Zum Teil, um den Wettbewerb einzuschr\u00e4nken, aber vor allem, um Zugang zu ihren Lieferketten und Produktionszentren zu erhalten. Sie sahen einen Nachfrageschub kommen und wollten ihm unbedingt zuvorkommen.\nUnd trotz dieser Bem\u00fchungen gibt es in einigen Ecken des Imperiums immer noch Engp\u00e4sse bei den Implantaten. Ich glaube, eine Person, mit der Sie gesprochen haben, beschrieb die Aufgabe, mit der Nachfrage Schritt zu halten, als das Verseuch, eine anbrandende Welle mit den Armen aufzufangen.\n\nSasha Bart: Diese Konsolidierungswelle hat einige Probleme mit sich gebracht. So hat ein gro\u00dfer Hersteller interne Software verwendet, die mit den Maschinen in mehreren der \u00fcbernommenen Anlagen nicht funktionierte. Diese Produktionslinien wurden wochenlang stillgelegt, bis die Software gepatcht war. Es hat sich auch als schwierig erwiesen, die Lieferkette zu beschleunigen, um die gestiegene Nachfrage zu befriedigen. Kybernetik ist kein einfaches Rohmaterial. Je nach Teil ben\u00f6tigen sie veredelte Materialien und Komponenten, von denen viele auch in anderen medizinischen Ger\u00e4ten verwendet werden. Viele dieser kybernetischen Hersteller k\u00f6nnen also ihre Produktionsl\u00e4ufe nicht erh\u00f6hen, wenn sie nicht bereit sind, exorbitante Preise f\u00fcr die richtigen Materialien zu zahlen.\nDas scheint diesen Sektor f\u00fcr viele Anleger auf den Punkt zu bringen: Gewinnpotenzial und so viel Risiko. Ich m\u00f6chte nun zu Ihrem neuesten Artikel kommen, in dem Sie mehrere Unternehmen aus der Medizin- und Versicherungsbranche vorstellen, die Ihrer Meinung nach boomen werden, und einige, die pleite gehen werden, aber vorher m\u00fcssen wir eine kurze Werbepause einlegen. Bleiben Sie hier, um weitere Einblicke von Sasha Bart von New United und mehr zu erhalten, wenn Kaizen zur\u00fcckkehrt.","zh_CN":"START TRANSMISSION:\nHi, thanks for joining another installment of Kaizen. I\u2019m Aaron Schere, here to help you set a course for financial solvency. Sasha Bart is back with us today to talk about potential profits and pitfalls in the booming medical and insurance industry. But first, it\u2019s time for a Market Breakdown.\n\nPast performance is not indicative of future results. Neither Schere, Kaizen, nor Farnes Media Partners guarantees any specific outcome or profit. Before acting on information in this program, you should strongly consider seeking advice from your own financial or investment adviser.\nMarkets are already on the move thanks to the IAE rumor mill. With this year\u2019s big event almost here, spectrum has been flooded with speculation and anonymous reports credited to \u201cindustry insiders.\u201d A quick reminder that the duration of the IAE remains an extremely volatile time for aerospace industry stocks. Investors should proceed cautiously as history has proven time and again that information leaked before the expo is often incomplete or simply wrong. That said, the gains and losses are still very real.\n\nRSI and Anvil have seen steady growth ahead of what many expect to be a strong showing from both manufacturers. Meanwhile, MISC\u2019s stock price has fluctuated wildly after a highly coordinated outlaw attack on one of its transports sparked rumors that its presence at the expo might be affected. MISC has publicly denied these claims and insisted that everything it needs for the main expo in Kiel is already in-system. Some noted the company specified Kiel but made no mention of the satellite expo on microTech, leaving some to wonder if the omission was a mistake or intentional. Since the initial rumors, MISC\u2019s stock price has stabilized after deal-seeking investors pounced on the falling price.\n\nNext, insurance giant Olympus Principal continues to expand its footprint across the empire. The company recently completed a series of buyouts of smaller insurance companies, most with a presence only in a single system. These takeovers will not only expand the insurance giant\u2019s client base, but also land it new locations in prime landing zones and rest stops across the empire. Investors were energized by the announcement and pushed Olympus Principal\u2019s stock to a new all-time high.\n\nHere with us today to discuss the current state of the medical and insurance industry is Sasha Bart, who\u2019s a senior economic correspondent for the New United and a frequent guest on this show.\n\nSasha Bart: Always a pleasure.\nYour latest series for the New United has focused on the medical and insurance sectors. The final installment that came out this week is the culmination of months spent delving into an ever-expanding and shifting financial landscape. It\u2019s a wonderful series and I highly encourage everyone to read it regardless of whether you\u2019re looking to invest.\n\nSasha Bart: Appreciate the kind words.\nYour most recent article profiled a handful of businesses and identified several potential booms and busts in both sectors. Before we drill down into the details, let\u2019s talk about the sector as a whole. Obviously, regen tech has had a profound effect on it.\n\nSasha Bart: Seismic. Both on a macroeconomic scale and a more personal one. One of my favorite parts of this assignment was tracking down several actuaries who were working for insurance companies when news of regen tech broke. As their primary focus is around risk management, needless to say, they have some wild stories about that time.\nI can only imagine.\n\nSasha Bart: Burnout became a serious issue, and many of them walked away from lucrative jobs. Insurance companies ran their actuaries ragged trying to figure out how to factor \u201cregen\u201d into their algorithms.\nDidn\u2019t one person you spoke to have to physically restrain a co-worker from jumping out the window?\n\nSasha Bart: In that one case, yes, but most reactions weren\u2019t that extreme. Several were even celebratory. And all of them had a specific memory about seeing the new projections or sharing them with co-workers for the first time.\nCelebratory? Seems a little presumptuous after an initial report.\n\nSasha Bart: Well, some saw the potential immediately. And that was before the UEE allocated trillions to help make regen tech widely available. That influx of credits combined with the public release of the Ibrahim Sphere blueprints so anyone could manufacture the tech sent the sector into QT.\nImperator Addison gets full credit for championing these measures, but several people you spoke with argued that it\u2019s been too much, too fast.\n\nSasha Bart: One person compared it to turning an Idris. It can be done fast and reckless or slow and steady. She worked for a small insurance firm with only a few branches in Ellis that struggled to process all the claims pouring in. Their system is mostly automated but some cases still need Human vetting. It was her and like three other people drowning in a backlog of claims.\nWeren\u2019t some of those government credits allocated just for businesses that needed to hire more employees or upgrade critical infrastructure?\n\nSasha Bart: Yes, and those credits definitely helped. Several businesses on my list told me that they wouldn\u2019t have been able to adjust to the new landscape without it. However, I discovered that in a lot of cases, particularly for small and medium sized insurance companies, buyout offers from giants like Olympus Principal were way more lucrative. Much less of a hassle too because, you know, they could just walk away with the credits instead of still running the business.\nConsolidation isn\u2019t only happening in the insurance sector it seems. You\u2019ve reported that there are fewer cybernetic manufacturers today than before regen tech came online.\n\nSasha Bart: Yeah, early numbers showed a sizable jump in the demand for cybernetics due to people\u2019s willingness to engage in riskier behavior. So larger manufacturers began bidding against each other to acquire smaller firms. Partially to limit competition, but mostly to gain access to their supply chain and manufacturing centers. They saw a surge in demand coming and were desperate to get ahead of it.\nAnd despite these efforts there are still shortages of implants in some corners of the empire. Believe one person you spoke to described the task of keeping up with the demand as trying to catch a crashing wave with your arms.\n\nSasha Bart: Several issues arose from this wave of consolidation, including one major manufacturer using in-house software that didn\u2019t work with the machines in several of the facilities they acquired. Those production lines were shut down for weeks until the software was patched. It\u2019s also proven hard to ramp up the supply chain to meet the increased demand. Cybernetics aren\u2019t simply raw materials. Depending on the part, they require refined materials and components, many of which other medical devices also use. So a lot of these cybernetic manufacturers can\u2019t increase their production runs unless they\u2019re willing to pay exorbitant prices for the right materials.\nThat seems to encapsulate this sector for many investors: potential for profit and so much risk. I\u2019d like to shift now to your latest article highlighting several medical and insurance businesses that you believe will boom and several that will bust, but before we do that, we need to take a quick commercial break. Stay here for further insights from the New United\u2019s Sasha Bart and more when Kaizen returns."},"links_count":0,"comment_count":12,"created_at":"2021-11-17T02:00:00+00:00","created_at_human":"4 years ago"},"meta":{"processed_at":"2026-04-26 03:18:02","valid_relations":["images","links","translations"],"prev_id":18430,"next_id":18433}}